However, in this previous study it was unclear whether IGF-II or the IGFBPs are associated with prostate cancer independently of IGF-I, and the analyses of associations with aggressive disease subtypes were underpowered to provide strong evidence of an effect.8 This evidence concerns the gene IGF2 and prostate carcinoma.